0000000000-18-018198.txt : 20181010 0000000000-18-018198.hdr.sgml : 20181010 20180613154312 ACCESSION NUMBER: 0000000000-18-018198 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20180613 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: ADiTx Therapeutics, Inc. CENTRAL INDEX KEY: 0001726711 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 823204328 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: 11161 ANDERSON STREET STREET 2: SUITE 105-10014 CITY: LOMA LINDA STATE: CA ZIP: 92354 BUSINESS PHONE: 909-488-0844 MAIL ADDRESS: STREET 1: 11161 ANDERSON STREET STREET 2: SUITE 105-10014 CITY: LOMA LINDA STATE: CA ZIP: 92354 PUBLIC REFERENCE ACCESSION NUMBER: 0001615774-18-002234 LETTER 1 filename1.pdf begin 644 filename1.pdf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filename2.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON , D .C . 20549 D IVI S IO N OF CO RP ORAT IO N FINANCE June 11, 2018 Amro Albanna Chief Executive Officer ADiTx Therapeutics, Inc. 11161 Anderson St., Suite 105-10014 Loma Linda, CA 92354 Re: ADiTx Therapeutics, Inc. Amendment No. 1 to Offering Statement on Form 1-A Filed on May 25, 2018 File No. 024-10825 Dear Mr. Albanna: We have reviewed your amended offering statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your offering statement and providing the requested information. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your offering statement and the information you provide in response to these comments, we may have additional comments. Unless we note otherwise, our references to prior comments are to comments in our April 26, 2018 letter. Amendment No. 1 to Offering Statement on Form 1-A General 1. We note that Article 9 of your Amended and Restated Certificate of Incorporation includes an exclusive forum provision. Please include disclosure in your offering statement, under "Securities Being Offered," at page 46, about the provision, its scope, its enforceability and its potential impact on the rights of investors. Please also include a risk factor to discuss the effects of the provision, including the possibility that the exclusive forum provision may discourage stockholder lawsuits, or limit stockholders' ability to bring a claim in a judicial forum that it finds favorable for disputes with the company and Amro Albanna FirstName LastNameAmro Albanna ADiTx Therapeutics, Inc. Comapany NameADiTx Therapeutics, Inc. June 11, 2018 June 11, 2018 Page 2 Page 2 FirstName LastName its officers and directors. 2. We note your disclosure throughout the offering statement that the minimum offering amount is "$6,000,000 of Units, or such greater amount of Units required for approval of [your] securities to commence trading on the NASDAQ Capital Market." Please revise throughout to remove references to the greater amount that may be required to receive Nasdaq approval and set a specific numeric amount for the minimum offering, or advise. Also, please advise how you plan to comply with Rules 10b-9 and 15c2-4 if you do not include a specific minimum offering amount. 3. Please refer to Exhibit 12.1. Please remove the first sentence in the last paragraph on page 1 of the opinion, as it appears to be an assumption regarding whether the shares are legally issued, or advise. Cover Page 4. We note your disclosure that "[t]he minimum investment is $600 (100 Units), however the Company reserves the right to accept investments for less than $600" and your reference to the Securities Being Offered section on page 46. We also note that there is no additional information about this minimum investment on page 46 or in any other section of the offering statement. Please revise to explain what criteria, if any, you will use to determine whether to accept investments in the amount of less than $600. Exhibits 5. Please file the executed copy of the Escrow Deposit Agreement,Exhibit 6.4, prior to qualification. 6. Please have counsel revise Exhibit 12.1 to also address the legality of the warrants and units. Refer to Section II.B.1.h of Staff Legal Bulletin No. 19, available on our website www.sec.gov. 7. We note the test the waters materials filed as exhibit 13.1. We also note that those materials indicate that a comprehensive list of the patent portfolio is available upon request. Please advise if, or how, that list differs from exhibit A, Patent Rights, in Exhibit 6.1, Patent and Technology License Agreement. If that is not the same information as you are requesting confidential treatment for, please provide us with the materials that you indicate are available upon request, as referenced in the test the waters materials. Also, please advise if the materials available upon request have been requested, and already given to potential investors. Amro Albanna ADiTx Therapeutics, Inc. June 11, 2018 Page 3 You may contact Abe Friedman at (202) 551-8298 or Jean Yu at (202) 551-3305 if you have questions regarding comments on the financial statements and related matters. Please contact Tonya K. Aldave at (202) 551-3601 or Susan Block at (202) 551-3210 with any otherquestions. FirstName LastNameAmro Albanna Division of Corporation Finance Comapany NameADiTx Therapeutics, Inc. Office of Transportation and Leisure June 11, 2018 Page 3 cc: Richard Friedman FirstName LastName